P13053 (VDR_RAT) Rattus norvegicus (Rat)
Vitamin D3 receptor UniProtKBInterProSTRINGInteractive Modelling
423 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
72 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitam… |
Heteromer Q15648; | 1×AKX; | ||||
| Assess | ||||||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer Q15648; | 1×W12; | ||||
| Assess | ||||||
| Crystal structure of VDR in complex with DLAM-4P (P21 form) |
Heteromer Q15648; | 1×VDP; | ||||
| Assess | ||||||
| Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis … |
Heteromer A1L0Z0; | 1×TT2; 1×EDO; 1×FMT; | ||||
| Assess | ||||||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer Q15648; | 1×T08; | ||||
| Assess | ||||||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer Q15648; | 1×O11; | ||||
| Assess | ||||||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer Q15648; | 1×W07; | ||||
| Assess | ||||||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer Q15648; | 1×LOA; | ||||
| Assess | ||||||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a s… |
Heteromer Q15648; | 1×VD2; | ||||
| Assess | ||||||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer Q15648; | 1×LHP; | ||||
| Assess | ||||||
| Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and … |
Heteromer Q15648; | 1×VD4; | ||||
| Assess | ||||||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a s… |
Heteromer Q15648; | 1×VD1; | ||||
| Assess | ||||||
| Vitamin D receptor complex with a carborane compound |
Heteromer Q15648; | 1×10S; | ||||
| Assess | ||||||
| Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and … |
Heteromer Q15648; | 1×VD5; | ||||
| Assess | ||||||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a sy… |
Heteromer Q15648; | 1×YR3; | ||||
| Assess | ||||||
| Vitamin D receptor with a synthetic ligand ADRO2 |
Heteromer Q15648; | 1×8J3; | ||||
| Assess | ||||||
| Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D comp… |
Heteromer Q15648; | 1×YW2; | ||||
| Assess | ||||||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a… |
Heteromer Q15648; | 1×TEJ; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with W282R mutation |
Heteromer D3ZRN2; | 1×VDX; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 |
Heteromer Q15648; | 1×YSV; | ||||
| Assess | ||||||
| A mixed population of antagonist and agonist binding conformers in a single crystal explains partia… |
Heteromer Q15648; | 1×YA1; | ||||
| Assess | ||||||
| Vitamin D3 receptor/lithochoric acid derivative complex |
Heteromer Q15648; | 1×FKF; 1×FMT; | ||||
| Assess | ||||||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer Q15648; | 1×3KL; | ||||
| Assess | ||||||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer Q15648; | 1×4OA; | ||||
| Assess | ||||||
| Vitamin D receptor complexed with a lithocholic acid derivative |
Heteromer Q15648; | 1×7SW; | ||||
| Assess | ||||||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synt… |
Heteromer Q15648; | 1×VDZ; | ||||
| Assess | ||||||
| VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3 |
Heteromer Q15648; | 1×YS3; | ||||
| Assess | ||||||
| Vitamin D receptor complex with a carborane compound |
Heteromer Q15648; | 1×10R; | ||||
| Assess | ||||||
| Crystal Structure of VDR-LBD/22S-Butyl-1a,24R-dihydroxyvitamin D3 complex |
Heteromer A1L0Z0; | 1×ICJ; | ||||
| Assess | ||||||
| Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis … |
Heteromer A1L0Z0; | 1×NYA; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 22S-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 |
Heteromer Q15648; | 1×YS9; | ||||
| Assess | ||||||
| A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-bindin… |
Heteromer A1L0Z0; | 1×JC1; | ||||
| Assess | ||||||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a e… |
Heteromer Q15648; | 1×9KR; | ||||
| Assess | ||||||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxy… |
Heteromer Q15648; | 1×VDX; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 22S-Butyl-25RS-(hydroxyphenyl)-25-methoxy-2-methylidene… |
Heteromer Q15648; | 1×8C0; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue |
Heteromer Q15648; | 1×YSL; | ||||
| Assess | ||||||
| Covalent labeling of rVDR-LBD by turn-on fluorescent probe mediated by conjugate addition and cycli… |
Heteromer Q15648; | 1×YSV; 1×EJO; | ||||
| Assess | ||||||
| Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis … |
Heteromer A1L0Z0; | 1×MI4; | ||||
| Assess | ||||||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having an … |
Heteromer Q15648; | 1×9KX; 1×9N9; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 22R-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1 ,2… |
Heteromer Q15648; | 1×YA2; | ||||
| Assess | ||||||
| Interaction between Vitamin D receptor (VDR) and a ligand having a dienone group |
Heteromer Q15648; | 1×9KX; | ||||
| Assess | ||||||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a v… |
Heteromer Q15648; | 1×9K0; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD/partial agonist complex: 22S-ethyl analogue |
Heteromer Q15648; | 1×YSE; | ||||
| Assess | ||||||
| A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-bindin… |
Heteromer A1L0Z0; | 1×JB1; | ||||
| Assess | ||||||
| Development of Novel Lithocholic Acid Derivatives as Vitamin D Receptor Agonists |
Heteromer Q15648; | 1×D0O; | ||||
| Assess | ||||||
| VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydr… |
Heteromer Q15648; | 1×YSD; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-… |
Heteromer Q15648; | 1×8BO; 1×9RO; | ||||
| Assess | ||||||
| A mixed population of antagonist and agonist binding conformers in a single crystal explains partia… |
Heteromer Q15648; | 1×YA1; | ||||
| Assess | ||||||
| Vitamin D3 receptor/lithochoric acid derivative complex |
Heteromer Q15648; | 1×FKC; 1×FMT; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trino… |
Heteromer Q15596; | 1×8C9; | ||||
| Assess | ||||||
| Vitamin D receptor with a synthetic ligand ADRO1 |
Heteromer Q15648; | 1×8J0; 1×FMT; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 25-(hydroxyphenyl)-2-methylidene-19,26,27-trinor-25-oxo… |
Heteromer Q15648; | 1×8BL; | ||||
| Assess | ||||||
| Crystal structure of VDR in complex with DLAM-2P |
Heteromer Q15648; | 1×DLC; | ||||
| Assess | ||||||
| VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha… |
Heteromer Q15648; | 1×YS5; | ||||
| Assess | ||||||
| Interaction between vitamin D receptor and coactivator peptide SRC2-3 |
Heteromer Q15596; | 1×VDX; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with an antagonist, 2-methylidene-19,26,27-trinor-22-(S)-but… |
Heteromer Q15648; | 1×8FF; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 25RS-(Hydroxyphenyl)-2-methylidene-19,26,27-trinor-1,25… |
Heteromer Q15648; | 1×8BF; | ||||
| Assess | ||||||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a sy… |
Heteromer Q15648; | 1×YR4; | ||||
| Assess | ||||||
| Crystal structure of VDR in complex with DLAM-4 (C2 form) |
Heteromer Q15648; | 1×VDP; | ||||
| Assess | ||||||
| VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvita… |
Heteromer Q15648; | 1×YS2; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with R270L mutation | monomer | 1×VDX; 1×EDO; 2×FMT; | ||||
| Assess | ||||||
| Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvi… | monomer | 1×TK3; 1×EDO; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with R270L mutation | monomer | 1×5YI; | ||||
| Assess | ||||||
| Crystal structure of rat vitamin D receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvi… | monomer | 1×TKA; | ||||
| Assess | ||||||
| 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis… | monomer | 1×VDB; | ||||
| Assess | ||||||
| 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis… | monomer | 1×VDX; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with W282R mutation | monomer | 1×YI3; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with R270L mutation | monomer | 1×YI2; | ||||
| Assess | ||||||
| Crystal structure of rat VDR-LBD with 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimeth… | monomer | 1×5YI; | ||||
| Assess | ||||||
| Crystal structures of rat VDR-LBD with W282R mutation | monomer | 1×YI4; | ||||
| Assess | ||||||
| Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvi… | monomer | 1×TKD; | ||||
| Assess | ||||||
| 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis… | monomer | 1×VDA; | ||||
| Assess | ||||||
8 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8f5y.1.A | monomer | 0.59 | 39.58 | |||
| Assess | ||||||
| 4nqa.1.B | monomer | 0.59 | 1×ZN; | 30.24 | ||
| Assess | ||||||
| 4nqa.2.B | monomer | 0.58 | 2×ZN; | 30.24 | ||
| Assess | ||||||
| 3dzy.1.B | monomer | 0.56 | 1×ZN; | 29.81 | ||
| Assess | ||||||
| 7prv.1.A | monomer | 0.53 | 2×ZN; | 21.57 | ||
| Assess | ||||||
| 7prv.1.B | monomer | 0.53 | 2×ZN; | 21.57 | ||
| Assess | ||||||
| 3dzy.1.A | monomer | 0.52 | 2×ZN; | 25.08 | ||
| Assess | ||||||
| 7kw7.1.F | monomer | 0.50 | 21.87 | |||
| Assess | ||||||